Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period 2017-30

July 30 15:04 2020
Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period 2017-30

Small Cell Lung Cancer Market | SCLC Market

Total Small-cell lung cancer incident cases are expected to increase with a CAGR of 1.7% for the study period 2017-30.

The total Small cell lung cancer incident cases patients were found to be more in males than in females in 7MM.

Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period 2017–30

DelveInsight’s ‘Small Cell Lung Cancer (SCLC)-Market Insights, Epidemiology and Market Forecast-2030’ report delivers an in-depth understanding of the SCLC, historical and forecasted epidemiology as well as the SCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom) and Japan.

 

Geography Covered – 7MM

  • The United States

  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)

  • Japan

 

Study Period: 2017-2030

 

Small Cell Lung Cancer (SCLC)- Disease Overview 

 

Small cell lung cancer (SCLC) or Small cell lung carcinoma is an aggressive and most malignant form of tumor, characterized by the uncontrolled, rapid growth of certain cells in the lungs. It accounts for almost 15% of all the lung cancers, the deadliest form of cancer in the world. 

 

The diagnosis of cancer mainly starts with a different set of tests that can be performed to examine cancer or for its better and effective treatment. 

 

Visit to know more about Small cell lung cancer market trends: https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

 

Small Cell Lung Cancer Epidemiological Analysis 

 

The Small Cell Lung Cancer epidemiology division provide insights about historical and current Small Cell Lung Cancer patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Small Cell Lung Cancer Epidemiology Key Highlights 

 

  • Total Small-cell lung cancer incident cases are expected to increase with a CAGR of 1.7% for the study period 2017-30.

  • The total Small cell lung cancer incident cases patients were found to be more in males than in females in 7MM.

 

Visit to read more: https://www.delveinsight.com/blog/small-cell-lung-cancer-market/ 

 

Small Cell Lung Cancer Epidemiological Segmentation 

 

The disease epidemiology covered in the report provides historical as well as forecasted Small Cell Lung Cancer epidemiology segmented into: 

  • Total Incident SCLC Patient Population

  • Gender-specific SCLC Incident Patient Population

  •  Age-specific SCLC Incident Patient Population

  •  Stage-Specific SCLC Incident Population

  • Line-wise Treatment of Extensive-Stage SCLC Incident Population 

Small Cell Lung Cancer Market

 

The Small Cell Lung Cancer market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted Small Cell Lung Cancer market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

Small Cell Lung Cancer Market Key Highlights

 

  • The small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30). 

  • Robust SCLC pipeline and increased healthcare spending are expected to change the dynamics of the ES-SCLC market. 

 

Request for free sample pages: https://www.delveinsight.com/sample-request/small-cell-lung-cancer-market

 

Small Cell Lung Cancer Marketed Therapies 

 

  • Opdivo (Nivolumab): Bristol-Myers Squibb

  • Keytruda (Pembrolizumab): Merck

 

Small Cell Lung Cancer Pipeline Therapies 

 

  • Imfinzi +/- tremelimumab: AstraZeneca

  • RRx-001: EpicentRx

  • Lurbinectedin (PM01183): PharmaMar

 

The SCLC market report provides current treatment practices, emerging drugs, SCLC market share of the individual therapies, current and forecasted SCLC market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current SCLC treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Know more about the report offerings: https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

 

Scope of the Report

  • The report covers the descriptive overview of Small Cell Lung Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

  • Comprehensive insight has been provided into the Small Cell Lung Cancer epidemiology and treatment in the 7MM

  • Additionally, an all-inclusive account of both the current and emerging therapies for Small Cell Lung Cancer is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

  • A detailed review of Small Cell Lung Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM

  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Small Cell Lung Cancer market

Tabe of Contents 

 

1.   Key Insights

2.   Executive Summary of SCLC

3.   SWOT Analysis for SCLC

4.   SCLC: Market Overview at a Glance

5.   Small Cell Lung Cancer (SCLC): Disease Background and Overview

6.   Epidemiology and Patient Population

7.   United States Small-cell Lung Cancer Epidemiology 

8.   EU-5 Country-wise Small-cell Lung Cancer Epidemiology

9.   Japan Small-cell Lung Cancer

10. Current Treatment Practices for Small-cell Lung Cancer (SCLC)

11. Patient Journey

12. Unmet Needs

13. Key Endpoints in SCLC Clinical Trials

14. Marketed Products

15. Emerging Therapies

16. Conjoint Analysis of Small Cell Lung Cancer (SCLC) Therapies

17. Small Cell Lung Cancer (SCLC): Seven Major Market Analysis

18. United States Market Size

18.1. Total Market size of SCLC in the United States

19. EU-5 Market Size

20. Japan Market Size

20.1. Total Market size of SCLC in Japan

21. Market Access and Reimbursement Scenario of SCLC Therapies

22. Market Drivers

23. Market Barriers

24. Appendix

24.1. Bibliography

24.2. Report Methodology

25. Disclaimer

26. DelveInsight Capabilities

27. About DelveInsight

 

Related Reports: 

Small Cell Lung Cancer – Epidemiology Forecast to 2030

DelveInsight’s ‘Small Cell Lung Cancer – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Small Cell Lung Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.  

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/